Sun Pharma Eyes Stronger US Presence With USD 10 Billion Organon Acquisition

SUMMARY

AI Generated Content
  • Sun Pharma eyes Organon acquisition for $10B.
  • Deal would boost Sun Pharma's US presence.
  • Organon focuses on women's health and biosimilars.
AD
AD